nifekalant hydrochloride has been researched along with A-V Dissociation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, K; Hashimoto, K; Satoh, Y; Sugiyama, A; Takahara, A | 1 |
| Hashimoto, K; Nakamura, H; Nouchi, H; Shigenobu, K; Shimada, H; Sugiyama, A; Takahara, A; Takeda, K; Tamura, M; Tamura, T; Tanaka, H; Tanaka, T; Tsuruoka, N | 1 |
2 other study(ies) available for nifekalant hydrochloride and A-V Dissociation
| Article | Year |
|---|---|
Electropharmacological and proarrhythmic effects of a class III antiarrhythmic drug nifekalant hydrochloride assessed using the in vivo canine models.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Cardiac Output; Dogs; Electrocardiography; Female; Heart Block; Heart Rate; Male; Models, Animal; Pyrimidinones; Vascular Resistance; Ventricular Pressure | 2004 |
Analysis of arrhythmogenic profile in a canine model of chronic atrioventricular block by comparing in vitro effects of the class III antiarrhythmic drug nifekalant on the ventricular action potential indices between normal heart and atrioventricular bloc
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Dose-Response Relationship, Drug; Heart Block; Heart Ventricles; Microelectrodes; Purkinje Fibers; Pyrimidinones | 2007 |